ABBV vs ECL
AbbVie Inc (ABBV) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ABBV and ECL stock pages for the full models.
Not investment advice.